Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$1.62 USD
-0.06 (-3.57%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $1.64 +0.02 (1.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Autolus Therapeutics PLC Sponsored ADR has a market cap of $447.12M, which represents its share price of $1.68 multiplied by its outstanding shares number of 266.14M. As a small-cap company, AUTL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AUTL 1.62 -0.06(-3.57%)
Will AUTL be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for AUTL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AUTL
AUTL's price falls by 2.33% on October 16, though its technical setup remains stable.
Longevity Biotech Surges as $72.6B Market Forecast Sparks Investment Rush
Longevity Biotech Surges as $72.6B Market Forecast Sparks Investment Rush
Crossed Above 50 Day Moving Average appears for AUTL after 6.17% move
Needham Hosts Virtual Meeting Featuring AUTL on October 22